Donate by 12/31
Research Grants - 2008


Alzheimer's Assocation Research only
All of alz.org
  • Go to Alz.org
  • Research Center
  • AAIC
  • ISTAART
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Home
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

Research Grants 2008


To view an abstract, select an author from the vertical list on the left side.

2008 Grants - Annaert

Targeting and Localization of Distinct Gamma-Secretase Complexes Versus APP

Willem Godfried Annaert, Ph.D.
Flanders Interuniversity Institute for Biotechnology
Leuven, Belgium

2008 Investigator-Initiated Research Grant

The protein fragment beta-amyloid may disrupt cell-to-cell communication and promote cell death in Alzheimer's disease. Beta-amyloid is clipped from its parent molecule, amyloid precursor protein (APP), in a two-stage process. During the second stage, the fragment is released by a protein complex known as gamma-secretase. Gamma-secretase also processes other proteins, including Notch, that may play important roles in nerve cell development. However, scientists do not know exactly how or why gamma-secretase targets different molecules.

Current research has found that a single neuron may contain diverse types of gamma-secretase complexes. Variations in gamma-secretase involve differences in presenilin genes and other key secretase components. One form of the presenilin gene, known as presenilin-1, tends to become mutated in people who acquire the familial (inherited) form of Alzheimer's. Scientists believe that different varieties of gamma-secretase may target different proteins.

For their proposed study, Willem Godfried Annaert, Ph.D., and colleagues hope to determine more precisely which forms of gamma-secretase target APP, Notch and other Alzheimer-related molecules. They also hope to learn more about the biological mechanisms underlying such interactions. For this effort, the team will use cultured cells and a high-resolution imaging technique. Results of the study could lead to better methods of preventing or reversing Alzheimer-related protein build-up in the brain.